• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Coherus hits FDA hurdles for PD-1 drug, Neulasta biosimilar on-body injector

cafead

Administrator
Staff member
  • cafead   Sep 25, 2023 at 08:22: PM
via After a complete response letter and delayed preapproval inspections, the FDA found a fresh problem at a clinical trial site for Coherus’ Junshi Biosciences-partnered toripalimab, Coherus said Monday.

article source
 

<